Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C2H3ClO |
| Molecular Weight | 78.498 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClCC=O
InChI
InChIKey=QSKPIOLLBIHNAC-UHFFFAOYSA-N
InChI=1S/C2H3ClO/c3-1-2-4/h2H,1H2
| Molecular Formula | C2H3ClO |
| Molecular Weight | 78.498 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Ifosfamide toxicity in cultured proximal renal tubule cells. | 2007-03 |
|
| The chloromethylketone protease inhibitor AAPF(CMK) also targets ATP-dependent helicases and SAP-domain proteins. | 2007-02-15 |
|
| Selective thiourea optical probe based on thiourea-induced removal of chloroacetyl group from chloroacetylamine. | 2006-12 |
|
| Thiol-mediated anchoring of ligands to self-assembled monolayers for studies of biospecific interactions. | 2006-11-21 |
|
| Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells. | 2006-11 |
|
| Synthesis of 2-alkenyl-3-(alkoxycarbonyl)furans based on Feist-Benary cyclocondensation of (2,4-dioxobutylidene)phosphoranes with alpha-haloketones and alpha-chloracetaldehyde. | 2006-10-13 |
|
| Selective alteration of the rate-limiting step in cytosolic aldehyde dehydrogenase through random mutagenesis. | 2006-08-08 |
|
| Ifosfamide-induced nephrotoxicity: mechanism and prevention. | 2006-08-01 |
|
| Efficient method for the deprotection of tert-butyldimethylsilyl ethers with TiCl4-Lewis base complexes: application to the synthesis of 1beta-methylcarbapenems. | 2006-07-07 |
|
| Enantioselective metabolism of ifosfamide by the kidney. | 2006-06 |
|
| [Increased urinary excretion of the neurotoxic side-chain metabolites of ifosphamide in children with polymorphism of the glutathione S-transferases genes]. | 2006-05-25 |
|
| Directed evolution of an industrial biocatalyst: 2-deoxy-D-ribose 5-phosphate aldolase. | 2006-05 |
|
| Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases. | 2006-05 |
|
| Ifosfamide: pharmacokinetic properties for central nervous system metastasis prevention. | 2006-05 |
|
| Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases. | 2006-04-24 |
|
| Insights into the hydrogen-abstraction reactions of diol dehydratase: relevance to the catalytic mechanism and suicide inactivation. | 2006-03-15 |
|
| A new protein superfamily includes two novel 3-methyladenine DNA glycosylases from Bacillus cereus, AlkC and AlkD. | 2006-03 |
|
| Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite. | 2006-02 |
|
| Hydroxyl-terminated dendritic oligomers from bile acids: synthesis and properties. | 2006-01-20 |
|
| Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells. | 2006-01 |
|
| Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy. | 2006 |
|
| Application of biological activated carbon anaerobic reactor for treatment of hazardous chemicals. | 2006 |
|
| Sequence-specific p53 gene damage by chloroacetaldehyde and its repair kinetics in Escherichia coli. | 2006 |
|
| Site specific synthesis and polymerase bypass of oligonucleotides containing a 6-hydroxy-3,5,6,7-tetrahydro-9H-imidazo[1,2-a]purin-9-one base, an intermediate in the formation of 1,N2-etheno-2'-deoxyguanosine. | 2005-11 |
|
| Disturbed Ca2+-signaling by chloroacetaldehyde: a possible cause for chronic ifosfamide nephrotoxicity. | 2005-11 |
|
| Mechanisms of solvolyses of acid chlorides and chloroformates. Chloroacetyl and phenylacetyl chloride as similarity models. | 2005-10-28 |
|
| ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. | 2005-10-04 |
|
| AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. | 2005-10 |
|
| Dynamic analysis of metabolic effects of chloroacetaldehyde and cytochalasin B on tumor cells using bioelectronic sensor chips. | 2005-10 |
|
| Ifosfamide-induced encephalopathy with or without using methylene blue. | 2005-09-22 |
|
| Enantioselective metabolism and cytotoxicity of R-ifosfamide and S-ifosfamide by tumor cell-expressed cytochromes P450. | 2005-09 |
|
| Synthesis, characterisation and theoretical calculations of 2,6-diaminopurine etheno derivatives. | 2005-08-21 |
|
| Palladium-catalyzed regioselective arylation of imidazo[1,2-b][1,2,4]triazine: synthesis of an alpha 2/3-selective GABA agonist. | 2005-07-22 |
|
| Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity. | 2005-07 |
|
| Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. | 2005-07 |
|
| Differential effects of Mg2+ ions on the individual kinetic steps of human cytosolic and mitochondrial aldehyde dehydrogenases. | 2005-06-07 |
|
| A tubule cell model for ifosfamide nephrotoxicity. | 2005-06 |
|
| [Optimization of transfection properties of DNA-lysine dendrimer complexes]. | 2005-05-14 |
|
| Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells. | 2005-03-15 |
|
| Matrix isolation and theoretical study of the photochemical reaction of CrCl2O2 with chloroethenes. | 2005-02-10 |
|
| One-step synthesis of labeled sugar nucleotides for protein O-GlcNAc modification studies by chemical function analysis of an archaeal protein. | 2005-01-26 |
|
| Polymorphisms of DNA repair gene XPD and DNA damage of workers exposed to vinylchloride monomer. | 2005 |
|
| Mismatch dependent uracil/thymine-DNA glycosylases excise exocyclic hydroxyethano and hydroxypropano cytosine adducts. | 2005 |
|
| DNA damage and mutations produced by chloroacetaldehyde in a CpG-methylated target gene. | 2004-12-21 |
|
| Role of mismatch-specific uracil-DNA glycosylase in repair of 3,N4-ethenocytosine in vivo. | 2004-12-02 |
|
| Renal ontogeny of ifosfamide nephrotoxicity. | 2004-12 |
|
| Analysis of drug action on tumor cell metabolism using electronic sensor chips. | 2004-12 |
|
| Degradation pathway of 2-chloroethanol in Pseudomonas stutzeri strain JJ under denitrifying conditions. | 2004-12 |
|
| Release of beta-nicotinamide adenine dinucleotide upon stimulation of postganglionic nerve terminals in blood vessels and urinary bladder. | 2004-11-19 |
|
| Suicide inactivation of dioldehydratase by glycolaldehyde and chloroacetaldehyde: an examination of the reaction mechanism. | 2004-10-06 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:27:51 GMT 2025
by
admin
on
Mon Mar 31 19:27:51 GMT 2025
|
| Record UNII |
CF069F5D9C
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
27871
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
m3379
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | Merck Index | ||
|
C004656
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
CF069F5D9C
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
CHLOROACETALDEHYDE
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
203-472-8
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
107-20-0
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
33
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
DTXSID4020292
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY | |||
|
2521
Created by
admin on Mon Mar 31 19:27:51 GMT 2025 , Edited by admin on Mon Mar 31 19:27:51 GMT 2025
|
PRIMARY |